🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jeffrey A. Rappaport

Johns Hopkins University

ORCID: 0000-0003-2695-1878

Also affiliated with University of Baltimore

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity”.

Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001046

N/A

0.970DataRank · unranked

38 citations

Jagmohan Singh, Robert D. Carlson, Elinor Leong, Trevor R. Baybutt, Joshua R. Barton +9 more

An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer

Expert Review of Clinical Pharmacology(2020)10.1080/17512433.2020.1826304

N/A

0DataRank · unranked

10 citations

Scott A. Waldman, Jeffrey A. Rappaport

A β-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal Cancer

Cellular and Molecular Gastroenterology and Hepatology(2021)10.1016/j.jcmgh.2021.12.014

N/A

0DataRank · unranked

12 citations

Ariana A. Entezari, Adi Caspi, Signe Caksa, Aakash Jhaveri, Timothy J. Stanek +8 more

Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy

npj Vaccines(2022)10.1038/s41541-022-00483-z

N/A

0DataRank · unranked

16 citations

Ross E. Staudt, Jagmohan Singh, Robert D. Carlson, Joshua R. Barton, Trevor R. Baybutt +6 more